7-OH: The Risks, the New Federal Law, and How Detox Works

Back to resources

Over the last couple of years, a new kind of product has spread across gas stations and smoke shops in Philadelphia and beyond: concentrated 7-OH tablets, shots, and gummies. Marketed as a stronger cousin of kratom, they've quietly become one of the fastest-growing dependence concerns providers are seeing — and a tightening federal law is now pushing more people toward treatment.

Here's what 7-OH actually is, why it's riskier than kratom leaf, what the new restrictions mean, and how to get help safely.

2025
the year the FDA moved to recommend scheduling 7-OH as a controlled substance
Trace
7-OH occurs only in tiny amounts in natural kratom leaf — these products concentrate it
Opioid-like
7-OH acts on the same mu-opioid receptors as morphine and other opioids

What is 7-OH?

7-OH is short for 7-hydroxymitragynine, one of the active compounds in kratom (Mitragyna speciosa). In the natural leaf it's present only in trace amounts — the main alkaloid is mitragynine. What's different now is a wave of concentrated and semi-synthetic 7-OH products that isolate and amplify this compound far beyond anything found in a plant.

That matters because 7-OH is substantially more potent at the brain's opioid receptors than mitragynine. In other words, these products behave much more like traditional opioids than like the herbal supplement people assume they're buying.

Why 7-OH products are riskier than kratom leaf

People often try 7-OH thinking it's "just kratom." It isn't. Because it's concentrated and opioid-like:

"People buy it thinking it's a supplement. Their body treats it like an opioid."

The new federal law on 7-OH

Regulators have taken notice. In 2025, the FDA moved to recommend that the DEA schedule 7-OH as a controlled substance and issued warning letters to companies selling concentrated 7-OH products. As those restrictions take hold and the supply tightens, providers across Philadelphia are seeing more people reach out for help — both because access is getting harder and because the health risks are becoming clearer.

If you've been relying on a 7-OH product to get through the day, a change in the law doesn't have to mean facing withdrawal alone.

Signs of 7-OH dependence & withdrawal

Because 7-OH acts on opioid receptors, withdrawal looks much like opioid withdrawal. It typically begins within 12–24 hours of the last dose and can include:

Physical symptoms often ease within about a week, but cravings and low mood can linger — which is why support beyond the first few days matters.

7-OH & kratom detox near you in Philadelphia

If you're searching for 7-OH detox or kratom detox near me, Philadelphia Recovery Solutions provides outpatient care in South Philadelphia. Because 7-OH and kratom act on opioid receptors, clinicians can use the same evidence-based tools proven for opioid use disorder — including medication such as buprenorphine (Suboxone) — to manage withdrawal and cravings. We coordinate medically supported detox when it's needed and continue care through our IOP and PHP programs, so the transition is safe and recovery lasts.

Philadelphia Recovery Solutions provides outpatient drug & alcohol treatment (IOP and PHP) for 7-OH and kratom dependence at our South Philadelphia location. Same-week intake available and most major insurance accepted. Get help today or call (215) 770-1694.

In crisis right now? Call or text 988 for the Suicide & Crisis Lifeline, or call 911 for an emergency.

Sources & further reading:
U.S. Food & Drug Administration (2025). FDA actions on 7-hydroxymitragynine (7-OH). fda.gov — National Institute on Drug Abuse. Kratom. nida.nih.gov — Weiss & Douglas (2021). Kratom withdrawal management with buprenorphine. Journal of Addiction Medicine. This article is for educational purposes and does not constitute medical advice.